HMGA2 and breast carcinoma: It has been shown to be activated by Wnt/β‐catenin signaling and repressed by the ZBRK1/BRCA1/CtIP pathway.32, 33 Yet, whether HMGA2 is involved in metformin‐associated breast cancer growth inhibition remains unclear.